Table 1.
Characteristic | SGA
|
Not SGA
|
p Value* | ||
---|---|---|---|---|---|
n | % | n | % | ||
Total | 221 | 2582 | |||
Age (years) | |||||
<20 | 10 | 4.5 | 216 | 8.4 | 0.35 |
20–24 | 64 | 29.0 | 551 | 21.3 | |
25–29 | 58 | 26.2 | 706 | 27.3 | |
30–34 | 45 | 20.4 | 747 | 28.9 | |
35+ | 44 | 19.9 | 362 | 14.0 | |
Missing | 0 | 0 | |||
Race/ethnicity | |||||
White non-Hispanic | 141 | 63.8 | 1690 | 65.5 | 0.14 |
Black non-Hispanic | 19 | 8.6 | 334 | 12.9 | |
Hispanic | 47 | 21.3 | 442 | 17.1 | |
Other | 14 | 6.3 | 116 | 4.5 | |
Missing | 0 | 0 | |||
Education (years) | |||||
<12 | 31 | 14.0 | 246 | 9.5 | 0.04 |
12 | 56 | 25.3 | 637 | 24.7 | |
>12 | 134 | 60.6 | 1697 | 65.8 | |
Missing | 0 | 2 | |||
Parity/number of previous live births | |||||
0 | 82 | 37.1 | 1148 | 44.5 | 0.15 |
1 | 92 | 41.6 | 895 | 34.6 | |
2+ | 47 | 21.3 | 539 | 20.9 | |
Missing | 0 | 0 | |||
Infant sex | |||||
Male | 121 | 54.8 | 1280 | 49.6 | 0.14 |
Female | 100 | 45.2 | 1302 | 50.4 | |
Missing | 0 | 0 | |||
Cigarette smoking† | |||||
Yes | 58 | 26.2 | 522 | 20.2 | 0.03 |
No | 163 | 73.8 | 2060 | 79.8 | |
Missing | 0 | 0 | |||
Secondhand smoking at home† | |||||
Yes | 53 | 24.0 | 463 | 17.9 | 0.03 |
No | 168 | 76.0 | 2119 | 82.1 | |
Missing | 0 | 0 | |||
Secondhand smoking at work† | |||||
Yes | 52 | 23.5 | 512 | 19.8 | 0.19 |
No | 169 | 76.5 | 2070 | 80.2 | |
Missing | 0 | 0 | |||
Alcohol drinking† | |||||
Yes | 108 | 48.9 | 1209 | 46.8 | 0.56 |
No | 113 | 51.1 | 1373 | 53.2 | |
Missing | 0 | 0 | |||
Prepregnancy body mass index | |||||
Underweight | 17 | 8.0 | 126 | 5.0 | 0.01 |
Normal weight | 136 | 63.8 | 1437 | 56.7 | |
Overweight | 36 | 16.9 | 588 | 23.2 | |
Obese | 24 | 11.3 | 385 | 15.2 | |
Missing | 8 | 46 | |||
Folate antagonist medication† | |||||
Yes | 1 | 0.5 | 2 | 0.1 | 0.22‡ |
No | 220 | 99.5 | 2580 | 99.9 | |
Missing | 0 | 0 | |||
Folic acid supplements† | |||||
Yes | 204 | 92.3 | 2437 | 94.4 | 0.20 |
No | 17 | 7.7 | 145 | 5.6 | |
Missing | 0 | 0 | |||
Household income ($) | |||||
<20 000 | 62 | 32.3 | 573 | 25.3 | 0.47 |
20 000–49 999 | 66 | 34.4 | 805 | 35.6 | |
50 000+ | 64 | 33.3 | 886 | 39.1 | |
Missing | 29 | 318 | |||
Study centre | |||||
Arkansas | 32 | 14.5 | 323 | 12.5 | 0.79 |
California | 23 | 10.4 | 306 | 11.9 | |
Iowa | 28 | 12.7 | 364 | 14.1 | |
Massachusetts | 32 | 14.5 | 370 | 14.3 | |
New Jersey | 34 | 15.4 | 347 | 13.4 | |
New York | 22 | 9.9 | 297 | 11.5 | |
Texas | 29 | 13.1 | 267 | 10.3 | |
CDC/Atlanta | 21 | 9.5 | 308 | 11.9 | |
Missing | 0 | 0 |
Probability calculated with χ2 test based on non-missing values.
Maternal exposure during the period from 1 month before conception through delivery.
Fisher’s exact test.